SARS-CoV-2 Antibody Neutralization Assay Platforms Based on Epitopes Sources: Live Virus, Pseudovirus, and Recombinant S Glycoprotein RBD

The high virulent severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus that emerged in China at the end of 2019 has generated novel coronavirus disease, coronavirus disease 2019 (COVID-19), causing a pandemic worldwide. Every country has made great efforts to struggle against SARS-CoV-...

Descripción completa

Detalles Bibliográficos
Autores principales: Septisetyani, Endah Puji, Prasetyaningrum, Pekik Wiji, Anam, Khairul, Santoso, Adi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Association of Immunologists 2021
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8733193/
https://www.ncbi.nlm.nih.gov/pubmed/35036026
http://dx.doi.org/10.4110/in.2021.21.e39

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8733193/
https://www.ncbi.nlm.nih.gov/pubmed/35036026
http://dx.doi.org/10.4110/in.2021.21.e39

Ejemplares similares